Bioethics, Psychedelic Therapy Abuse, and the Risk of Ethics Washing
What challenges arise for bioethicists when taking on commissions to work for organizations that are emerging out of the psychedelic underground?
Mental Health
-
Read more: Bioethics, Psychedelic Therapy Abuse, and the Risk of Ethics Washing -
Read more: Let Go and Surrender: Considerations on MDMA Couples Therapy and Coercive Control Let Go and Surrender: Considerations on MDMA Couples Therapy and Coercive Control
Historic and contemporary discussions on psychedelic and MDMA research largely ignore theories on power, control, and abusive interpersonal relationships.
-
Read more: A Brief Political Economy of Hype A Brief Political Economy of Hype
It is only through public funding, regulation, and democratic community efforts that opportunities will expand, inequality diminish, and health care improve.
-
Read more: Beyond the Psychedelic Competitive Moat: Chasing the Patent Dragon Beyond the Psychedelic Competitive Moat: Chasing the Patent Dragon
Here, we examine hype in the context of a perennial tension at the heart of patenting communication: between advertising innovation and keeping it secret.
-
Read more: When the Promises of a Policy Do Not Meet the Reality of Its Practice: Ethical Issues Within Oregon’s Measure 109 When the Promises of a Policy Do Not Meet the Reality of Its Practice: Ethical Issues Within Oregon’s Measure 109
In short, 109’s creators’ stated intent to make psilocybin therapy accessible to help the growing mental health care crisis has resulted in a policy that doesn’t allow for any of it.
-
Read more: History Rhymes with the Psychedelic Boom History Rhymes with the Psychedelic Boom
As a historian of psychoactive pharmaceuticals in the 20th century U.S., I see history rhyming in potentially dangerous ways in the current psychedelic boom.
-
Read more: Psychedelics in the Clinical Setting: The Potential for Harm and the Promise of Healing Psychedelics in the Clinical Setting: The Potential for Harm and the Promise of Healing
There are a number of unique issues that psychedelics present in a clinical setting that are yet to be adequately addressed.
-
Read more: Introductory Editorial — Critical Psychedelic Studies: Correcting the Hype Introductory Editorial — Critical Psychedelic Studies: Correcting the Hype
As we move past a phase of “partial eclipse” by psychedelic hype, this critical field is finally well-situated to explore the full spectrum of psychedelic effects.
-
Read more: Addressing Ghost Networks in Mental Health Care Addressing Ghost Networks in Mental Health Care
Many mental health provider directories contain inaccurate or outdated provider information, which creates a misleading illusion of accessible care.
-
Read more: Ketamine Is the New Viagra Ketamine Is the New Viagra
A combination of high demand and a patent monopoly has created a perfect storm of profitability for Janssen’s Spravato.
